Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Mtr3g2199 | ATGACTCCGAATTTGGAATGTCGCATGTACGAGGCAAGGTACCCGGAGGTAGACACGGCGGTGATGATACAGGTGAAGAACATCGCCGACATGGGTGCATACGTTTCACTTCTCGAATACAACAATATCGAGGGTATGATTCTGTTCTCCGAGCTTTCTCGCCGTCGAATTCGTAGTGTTAACAGTCTGATCAAGGTTGGTCGAACCGAACCGGTGATGGTTCTTCGTGTTGACAAAGAAAAGGGTTACATTGATCTTAGTAAACGTAGGGTTTCTGAAGAAGATATTCAAGCTTGTGAAGAAAGGTATAATAAGAGTAAACTTGTGCATTCTATTATGCGCCATGTTGCTGAAACCTTGGACCTTGATTTAGAGGAGCTTTATGTTCACATTGGATGGCCTTTGTATCGCAAATATGGTCATGCTTTTGAGGCGTTCAAGATAGCTGTGGCCAATTCTGATACGGTTTTGAGCCCTCTAATGCGTGAAATCAAGGAAGTTGGTCCTGATGGGAAAGCGGTGACCAAGGTGGTACCTTCTGTGTCTGAAGAAATGAAGAATTCTCTACTGATGAACATTAGAAGACGAATGACCCCTCAGCCATTCAAAATCAGGGCGGACATTGAAATGAAATGTTTTCAATTTGATGGAATTATACACATTAAGGAGGCAATGCAGAAGGCTGAAGCTGCTGGAAATGATGACTGCCCTGTGGAAATTAAACTTGTTGCTCCCCCACTTTATGTGCTTACCACTCAGACCCTTGACAAGGAGCAAGGAAAATTGGTTCTACGCAATGCCATTGCTTGTTGCACTGAATCAATAGAAAAACATAAGGGTAAACTTATGCTGGTGAAGGAAATTAGAGCGGATGTCGATGGTGATGGCCCATTTCCAATTACTCCGATTCAGAATGAAAATAATGATGATGTCAGTAGCGATGAAGACAGTGAAGAGGAAGAAGATACTGGAATGGGCGAGGTTGATGTGGAGAATGGTAATGCGATAATGGAGTGA | 1017 | 0.4317 | MTPNLECRMYEARYPEVDTAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRIRSVNSLIKVGRTEPVMVLRVDKEKGYIDLSKRRVSEEDIQACEERYNKSKLVHSIMRHVAETLDLDLEELYVHIGWPLYRKYGHAFEAFKIAVANSDTVLSPLMREIKEVGPDGKAVTKVVPSVSEEMKNSLLMNIRRRMTPQPFKIRADIEMKCFQFDGIIHIKEAMQKAEAAGNDDCPVEIKLVAPPLYVLTTQTLDKEQGKLVLRNAIACCTESIEKHKGKLMLVKEIRADVDGDGPFPITPIQNENNDDVSSDEDSEEEEDTGMGEVDVENGNAIME* | 339 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Mtr3g2199 | 338 | Pfam | Eukaryotic translation initiation factor 2 alpha subunit | 127 | 257 | IPR011488 | GO:0003723|GO:0003743 | |
Mtr3g2199 | 338 | MobiDBLite | consensus disorder prediction | 309 | 327 | - | - | |
Mtr3g2199 | 338 | CDD | S1_IF2_alpha | 15 | 90 | IPR044126 | GO:0003723 | |
Mtr3g2199 | 338 | PANTHER | EUKARYOTIC TRANSLATION INITIATION FACTOR 2 SUBUNIT 1 | 2 | 338 | IPR011488 | GO:0003723|GO:0003743 | |
Mtr3g2199 | 338 | SUPERFAMILY | Nucleic acid-binding proteins | 13 | 94 | IPR012340 | - | |
Mtr3g2199 | 338 | SMART | S1_6 | 16 | 89 | IPR022967 | - | |
Mtr3g2199 | 338 | MobiDBLite | consensus disorder prediction | 295 | 338 | - | - | |
Mtr3g2199 | 338 | PANTHER | BNAC04G04870D PROTEIN | 2 | 338 | - | - | |
Mtr3g2199 | 338 | Gene3D | Translation initiation factor 2; subunit 1; domain 2 | 92 | 196 | IPR024054 | - | |
Mtr3g2199 | 338 | ProSiteProfiles | S1 domain profile. | 18 | 89 | IPR003029 | GO:0003676 | |
Mtr3g2199 | 338 | SUPERFAMILY | eIF2alpha middle domain-like | 91 | 196 | IPR024054 | - | |
Mtr3g2199 | 338 | SUPERFAMILY | eIF-2-alpha, C-terminal domain | 200 | 308 | IPR024055 | - | |
Mtr3g2199 | 338 | Gene3D | - | 3 | 91 | IPR012340 | - | |
Mtr3g2199 | 338 | Pfam | S1 RNA binding domain | 15 | 89 | IPR003029 | GO:0003676 | |
Mtr3g2199 | 338 | Gene3D | EIF_2_alpha | 202 | 323 | IPR024055 | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Mtr3g2199 | Mtr-Chr3 | 35594047 | 35598503 | Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Mtr3g2199 | 2 | 338 | Eukaryotic Initiation Factors Gene Family | AT5G05470 | 70.000 | 2.54e-162 | 455 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Mtr3g2199 | K03237 | - | gmx:100805950 | 520.005 |